GE HealthCare announced that its Photonova Spectra photon-counting CT system has received FDA clearance, marking a key step toward commercial deployment in the U.S.

The system introduces advanced photon-counting technology with ultra-high resolution imaging and improved tissue characterization, enabling clinicians to detect subtle abnormalities and make more precise diagnoses from a single scan.

Designed to handle significantly larger data volumes using NVIDIA-powered computing, the platform aims to enhance workflow efficiency and support more accurate, data-rich clinical decision-making.
Business Wire